Microwave ablation (MWA) is a thermal ablation technology with a growing clinical footprint across liver, lung, kidney, bone, and a range of solid tumors. MWA works by delivering electromagnetic energy directly into tissue through an antenna embedded in a minimally invasive, needle-sized applicator. The target tissue is then heated to temperatures high enough to cause nearly instantaneous cell death.

The underlying physics will be familiar to anyone who has used a kitchen microwave oven to warm their food. Although many clinical MWA systems use the same operating frequency as a kitchen oven, the critical difference is the approach. A kitchen oven heats food from the outside in, radiating the food with microwave energy from all directions. An MWA applicator heats tissue from the inside out, radiating energy outward from an antenna within the target tumor.

That inside-out geometry is what lets MWA concentrate lethal temperatures within a defined volume of tissue while leaving surrounding structures safe. Understanding what MWA does to tissue, and what governs the size, shape, and predictability of the ablation zone, is the foundation for designing systems that perform reliably across the range of conditions they will encounter clinically. 

This article summarizes the tissue effects of microwave ablation, drawn from our experience at Engenious Design developing microwave ablation systems, including novel directional applicators, bronchoscopic applicators, and generator platforms across multiple clinical applications. 

1. The microwave heating mechanism 

Biological tissue contains many molecules that respond to an oscillating electric field: water is the most abundant and the strongest absorber at microwave frequencies, but proteins, lipids, and other polar molecules also contribute to the heating process. Water molecules are electrically asymmetric — the oxygen atom is slightly negative, and the hydrogen atoms are slightly positive — and therefore they act like tiny compass needles that want to flip orientation every time the externally applied electric field reverses direction.

At microwave frequencies, the field reverses billions of times per second. The molecules cannot keep up, and that lag between the field and the molecule generates friction. That friction generates heat.

This heating process, called dielectric heating, occurs throughout the volume of tissue exposed to the field, not just at a surface or electrode tip. That volumetric character distinguishes microwave ablation from radiofrequency ablation. 

The amount of heat generated at any point in tissue depends on two factors: how strong the electric field is at that location, and how well that tissue absorbs microwave energy. These factors vary with tissue type, temperature and frequency. As a result, the MWA applicator design cannot be separated from the tissue it is meant to treat: an antenna tuned for liver may perform very differently in lung or bone.^[1]

Why microwave ablation is not limited by tissue impedance 

In radiofrequency ablation (RFA), the targeted tissue is part of the electrical circuit: current flows from the electrode, through tissue, and returns to a dispersive ground pad (or another electrode). As the tissue nearest the electrode heats and desiccates, its electrical resistance rises sharply, the circuit delivers less energy to the tissue, and growth of the ablation zone stalls. This impedance roll-off is the fundamental reason ablation zones in RFA are limited in size, and why RFA systems often use pulsed energy delivery to allow partial rehydration of tissue during treatment. 

Microwave ablation does not work this way. The microwave field radiates outward from the antenna into tissue the way a radio signal radiates into air. Tissue resistance does not gate the delivery, because there is no resistive circuit the way there is in RFA.

How far and how effectively the field penetrates is determined by the tissue's ability to absorb and transmit microwave energy at the operating frequency, not by its local electrical resistance. This is why MWA can deliver power continuously at levels far above what RFA can sustain, why it can heat tissue with high electrical resistance like lung and bone that defeat RFA, and why it does not require pulsed delivery to manage the impedance ceiling that limits RFA.^[2,3] 

How tissue composition affects heating 

Water is the dominant absorber of microwave energy in tissue, so water content is the strongest predictor of how well a given tissue type heats. Soft organs (liver, kidney, muscle) and most solid tumors have high water content and absorb microwave energy readily. Fat has much lower water content and heats poorly. Proteins and other biomolecules contribute to absorption as well, which is why tissue composition as a whole — not just water fraction — determines the heating response.

Lung parenchyma, which is mostly air-filled, is a poor microwave absorber overall, but solid pulmonary tumors retain high water and protein content and heat more effectively relative to the surrounding aerated lung. This is an important practical advantage for microwave ablation in the lung.^[3,4] Metastatic bone tumors may also heat much more effectively relative to surrounding healthy bone, which is a poor absorber due to its dense mineral structure and low water content. 

How tissue changes during heating, and why it matters 

As tissue heats, its ability to absorb microwave energy changes, and those changes feed back into the pattern of heating. This is one of the most important and least intuitive aspects of microwave ablation. At temperatures approaching 80 to 100°C, tissue water begins to evaporate, and proteins are fully denatured. As water is driven out and tissue structure breaks down, the tissue absorbs microwave energy less effectively in the region immediately adjacent to the applicator.^[1] The practical effect is that the heating pattern shifts during the procedure: early on, heating concentrates near the antenna tip; as that tissue desiccates and loses its water, the microwave field penetrates further into wetter, intact tissue beyond. This is why ablation zone growth is not linear over time, and why device models that assume fixed tissue properties throughout the procedure are less accurate than those that account for these changes.^[1,5]

2. The ablation zone: how it forms and what governs its shape 

The ablation zone in microwave ablation is the volume of tissue that reaches temperatures sufficient for irreversible cell death. That threshold is not a fixed number — it is a tradeoff between temperature and time. Tissue held at around 46°C for roughly an hour sustains irreversible damage, but that same outcome occurs in 4 to 6 minutes at 50–52°C, and in seconds at temperatures above 60°C.^[2,6] In practice, clinical microwave ablation protocols aim to drive the entire target volume above 60°C to ensure rapid, reliable cell kill throughout, rather than relying on the slower kinetics that operate at lower temperatures. Temperatures above about 100°C cause tissue water to boil and vaporize, which can disrupt energy delivery and create unpredictable heat transfer effects in tissue.^[1,2] 

The three zones of a microwave ablation 

A fully developed microwave ablation treatment zone has a characteristic three-zone structure visible when the tissue is sectioned after treatment: 

• The ablation core (the area immediately surrounding the tip of the applicator) has been heated to very high temperatures, typically above 100°C. Tissue here is fully dried out, sometimes charred, and structurally disrupted. Cell death is complete and irreversible.

• The ablation zone (the main treatment volume) has reached sustained lethal temperatures (above 54–60°C). Cells are killed, but the gross tissue structure is largely intact in the short term, which is why this zone looks different from the core but is still fully non-viable.^[2,6]

• The transition zone (at the outer margin) has reached temperatures that are damaging but not immediately lethal. Cells in this zone may be injured but still alive, or they may die over the hours to days following treatment. This outer margin is the most consequential zone from a treatment outcome standpoint: any tumor tissue left in it is the most likely source of local recurrence.^[3,7]

Ablation shape 

Standard linear antenna designs, like those used in microwave ablation applicators, radiate maximally in the radial direction (perpendicular to the antenna axis) and minimally along the axis itself. The resulting power absorption pattern is roughly toroidal (donut-shaped) around the antenna. However, most clinical microwave ablation applicators produce ellipsoidal ablation zones that are elongated along the applicator's axis, with the long axis running from the tip toward the handle. This is in part because the active length of the antenna can be as long as, or longer than, the absorption depth of microwaves in tissue, and because thermal conduction from heated tissue can extend the ablation zone axially.^[5,8]

A further complication is the ablation "tail": heating along the outer conductor of the coaxial transmission line that feeds the antenna produces a zone of tissue heating proximal to the intended target, extending up the applicator shaft. This tail is a known artifact of unbalanced antenna designs and is mitigated in practice by active water cooling of the applicator shaft and by antenna design features (chokes, sleeves) that suppress current flow along the outer conductor. Despite these countermeasures, a residual tail is present in most commercial applicators and should be accounted for in treatment planning.^[5,8]

Directional microwave ablation: reshaping the zone by design 

One limitation of conventional MWA applicators is that their nearly cylindrically symmetric radiation pattern (as described above) often cannot be reliably positioned to avoid harming critical anatomy. If a tumor abuts the gallbladder, diaphragm, or the spinal cord, for example, the treating physician must either accept the risk of thermal injury to that structure, apply thermoprotective techniques (hydrodissection, gas dissection, endoluminal cooling) to create separation, or decline to treat.^[9]

Directional microwave ablation (dMWA) applicators address this by integrating metallic reflector elements into the applicator shaft that restrict microwave radiation to a preferred angular half-space, producing a hemispherical rather than cylindrically symmetric ablation zone. Our team has experience developing experimental dMWA applicators that let the operator direct energy toward the tumor and away from structures that should not sustain thermal injury, an approach applied to adrenal and spinal indications in animal studies.^[10,11]

3. What microwave ablation does to specific tissue types 

MWA heats tissue based on its composition and the local field strength, without discriminating between cell types. A tumor cell and the wall of the bile duct next to it respond to the same field and reach the same temperature if they share the same location. Everything in the ablation zone that reaches lethal temperature is destroyed. This is both MWA's strength (reliable, complete cell kill within the treatment zone) and the core engineering challenge (keeping lethal temperatures confined to the target and away from structures that cannot be sacrificed). 

Working cells: completely destroyed 

The functional cells of the target organ (liver cells, kidney cells, lung cells, adrenal cells) are the intended targets of MWA and are reliably destroyed within the ablation zone. Cell death is complete within the central and main ablation zones. At the outer margin, cell kill becomes probabilistic, which is why treatment protocols target temperatures well above the minimum lethal threshold at the intended treatment boundary.^[2,6]

Blood vessels: open but potentially damaged 

Small vessels (below approximately 3 mm in diameter) within the ablation zone are typically sealed and destroyed by the heat. Larger vessels are more resistant to thermal injury for two reasons: their walls are thicker and more heat-tolerant, and blood flowing through the vessel continuously carries thermal energy away from the wall before it can accumulate to lethal levels.

This cooling effect of blood flow is a recognized limitation of MWA and can result in viable tumor tissue surviving immediately adjacent to a large vessel even when the surrounding tissue is completely destroyed.^[3,7] This pattern of recurrence at the vessel margin is well documented in liver tumors treated near the major hepatic veins and is a common driver of incomplete local treatment in highly vascular target sites. 

Bile ducts and ureters: vulnerable to heat injury 

The thin inner lining of a bile duct or ureter can be damaged at temperatures lower than those required to destroy the surrounding tissue, and the duct wall, once thermally injured, may heal with permanent narrowing rather than full recovery. Narrowing of major bile ducts following MWA of centrally located liver tumors is a recognized complication that limits where thermal ablation can safely be applied.^[9] Injecting saline or CO₂ between the duct and the ablation zone (a technique called hydrodissection or gas dissection) to create physical separation is standard practice in difficult cases, but adds steps and is not always feasible. Directional MWA can reduce the energy directed toward a duct, but cannot fully protect it when the tumor and duct are inseparable.^[9,10]

Nerves: collateral risk depends on proximity and temperature 

Nerves are susceptible to both direct thermal destruction within the ablation zone and heat injury in the transition zone that can result in temporary or permanent loss of function. The temperature threshold for nerve damage is lower than for tissue destruction: temperatures above roughly 45°C held for several minutes can injure nerve fibers, and temperatures above 60°C cause irreversible structural damage.^[6,13] This means the outer margin of an MWA treatment zone, which extends beyond the grossly visible zone, represents a risk zone for any nerve running nearby.^[6,9] Applicator placement and treatment planning are the primary mitigations. Where critical nerves are very close to the treatment target (for example, the nerve that controls breathing during chest procedures, or nerves running between the ribs), hydrodissection or gas dissection is used to create physical separation. 

Bone and the spinal cord: a precision challenge 

MWA may be preferred over RFA for osseous metastases because high cortical bone impedance defeats RFA's current-based heating mechanism, while microwaves propagate through bone regardless of its resistance. However, treating vertebral metastases requires heating the lesion while protecting the spinal cord, which may be separated from the ablation target by only a few millimeters of bone.^[11] Conventional symmetric MWA applicators cannot reliably hold that margin. Directional MWA, by confining the ablation zone to the anterior or lateral vertebral body, can spare the posterior elements and spinal canal.^[11]

4. Engineering implications 

The tissue-level physics of MWA translate directly into the hardware and software decisions that determine whether a system performs reliably. A few of the most consequential engineering implications, from our experience designing MWA systems: 

• Antenna design determines zone geometry. The shape of the ablation zone is not primarily a function of power or time. It is determined by the antenna's radiation pattern, which is set by the antenna geometry, the materials used inside the applicator (including any insulating medium surrounding the inner conductor and the cooling water), and how well the antenna is matched to the cable feeding it at the operating frequency. Changing power changes zone size. Changing antenna design changes zone shape. Our team designs applicators using computational models that couple the electromagnetic-field simulation with heat-transfer simulation, tracking how the ablation zone grows as tissue properties change during heating, not just the initial heating pattern.^[1,5]

• Applicator active cooling is an important design parameter. Active water or gas cooling of the applicator shaft serves two functions: it protects the cable from overheating at power levels above its rated maximum, and it prevents tissue along the shaft from heating proximal to the target. However, excessive cooling may shrink the maximum achievable ablation zone. Flow rate, water inlet temperature, and flow path geometry all affect both cable protection and the spatial pattern of tissue heating. Active cooling setpoints are engineering parameters that must be characterized experimentally across the full intended operating range.^[1,8]

• Operating frequency is a system-level design decision. The two standard MWA frequencies are 915 MHz and 2.45 GHz, though some developmental work has been done at higher frequencies. At 915 MHz, the field penetrates tissue more deeply; at 2.45 GHz, the field is absorbed more rapidly near the antenna. The choice of frequency also affects antenna dimensions, with 915 MHz antennas being physically longer than 2.45 GHz versions. Combining these two effects, 2.45 GHz systems typically produce more compact zones with higher power density near the antenna.

• Generator architecture must support active power monitoring. Unlike RFA generators, which monitor tissue impedance as a treatment indicator, MWA generators must measure how efficiently the antenna is transferring power into tissue by comparing how much power is sent forward to the antenna versus how much bounces back. This ratio changes as tissue properties evolve during ablation and can signal whether the ablation is progressing normally, whether the antenna is poorly positioned, or whether the system has a fault. Some experimental work on transmission-based monitoring has shown that measuring the electromagnetic signal between paired applicators can detect whether their ablation zones have merged into a single continuous zone.^[12]

• Thermoprotection should be part of the treatment planning workflow, not an afterthought. For indications where the ablation margin is expected to approach a critical structure, the thermoprotective strategy (hydrodissection fluid volume and injection point, gas dissection, or directional applicator orientation) should be specified in the device's intended use documentation and clinical protocol, with supporting data from benchtop and animal studies. Regulators increasingly expect to see this specificity in 510(k) submissions for devices with challenging anatomic indications.^[9]

Conclusion 

Microwave ablation destroys its clinical targets by radiating electromagnetic energy that converts to heat when absorbed in tissue. Ablation zone size and shape are determined by the antenna's radiation pattern, by tissue composition and how that composition changes as it heats, and by the applicator's internal cooling system.

Shaping the treatment zone to cover the entire target tumor, while keeping it away from structures that would harm the patient if they were thermally injured, is an engineering problem that starts at the antenna design stage and runs through generator architecture, treatment planning, and clinical protocol specification. 

MWA has meaningful and well-documented limitations: the heat-sink effect from large vessels, the risk of collateral thermal injury to bile ducts and nerves, and the inability of conventional symmetric applicators to direct energy away from adjacent critical structures.

These are not reasons to avoid MWA. They are design requirements that define what a better MWA system looks like. Our team's work on directional MWA applicators, bronchoscopic delivery systems, and intraprocedural monitoring methods is aimed directly at those limitations. 

Our team at Engenious Design has developed over 20 ablation systems across a range of energy modalities including MWA, RFA, and pulsed field ablation (PFA). If you are developing an MWA system and want an experienced engineering team on your side, contact us at connect@engenio.us. 

‍

References

1. Prakash P. Principles and technologies for electromagnetic-based tissue ablation. Engineering in Medicine and Biology Society, Academic Press (Elsevier). 2022.

2. Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?. Curr Probl Diagn Radiol. 2009;38(3):135–143. doi:10.1067/j.cpradiol.2007.10.001

3. Lubner MG, Brace CL, Hinshaw JL, Lee FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21(8 Suppl):S192–S203. doi:10.1016/j.jvir.2010.04.007

4. Sebek J, Kramer S, Rocha R, et al.. Bronchoscopically delivered microwave ablation in an in vivo porcine lung model. ERJ Open Res. 2020;6(4):00146–2020. doi:10.1183/23120541.00146-2020

5. Pfannenstiel A, Iannuccilli J, Cornelis FH, Dupuy DE, Beard WL, Prakash P. Shaping the future of microwave tumor ablation: a new direction in precision and control of device performance. Int J Hyperthermia. 2022;39(1):664–674. doi:10.1080/02656736.2021.1991012

6. Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208. doi:10.1038/nrc3672

7. Donlon P, Dennedy MC. Thermal ablation in adrenal disorders: a discussion of the technology, the clinical evidence and the future. Curr Opin Endocrinol Diabetes Obes. 2021;28(3):291–302. doi:10.1097/MED.0000000000000627

8. Fallahi H, Prakash P. Antenna designs for microwave tissue ablation. Crit Rev Biomed Eng. 2018;46(6):495–521. doi:10.1615/CritRevBiomedEng.2018028554

9. Garnon J, Cazzato RL, Caudrelier J, et al.. Adjunctive thermoprotection during percutaneous thermal ablation procedures: review of current techniques. Cardiovasc Intervent Radiol. 2019;42(3):344–357. doi:10.1007/s00270-018-2089-7

10. Pfannenstiel A, Sebek J, Fallahi H, et al.. Directional microwave ablation: experimental evaluation of a 2.45-GHz applicator in ex vivo and in vivo liver. J Vasc Interv Radiol. 2020;31(8):1270–1277. doi:10.1016/j.jvir.2020.01.016

11. Pfannenstiel A, Avellar H, Hallman C, et al.. Directional microwave ablation in spine: experimental assessment of computational modeling. Int J Hyperthermia. 2024;41(1):2313492. doi:10.1080/02656736.2024.2313492

12. Zeinali N, Pfannenstiel A, Hallman C, et al.. Transmission-based monitoring of dual-applicator microwave ablation discriminates discontiguous from contiguous ablation zones in an in vivo porcine liver model. J Vasc Interv Radiol. 2025;36(5):884–893.e3. doi:10.1016/j.jvir.2024.12.005

13. Haveman J, Sminia P, Wondergem J, van der Zee J, Hulshof MC. Effects of hyperthermia on the central and peripheral nervous systems: a review. Int J Hyperthermia. 2004;20(3):311–325. doi:10.1080/02656730310001637631